Heart Attack Diagnostics Market Trends

Growth Drivers

Rise in Geriatric Population Worldwide - Globally, there were 747,238,580 people over 60 years old at the end of 2021 according to a recent World Bank report. Future projections indicate an increase in the number. Cardiovascular disease is more prevalent among the elderly and the aging population. Adults with cardiovascular disease are at an increased risk of CVD owing to their age, which is increased by contributing factors such as fragility, overweight, and diabetes. Moreover, aging populations are more likely to suffer from heart attacks because they are more vulnerable to heart diseases.

Higher Level of Cholesterol Among People- As per the data by the Centers for Disease Control and Prevention, the total cholesterol level of nearly 94 million U.S. adults aged 20 or older exceeds 200 mg/dL. A total of 28 million Americans has a cholesterol level above 240 milligrams per deciliter.
Increasing Consumption of Alcohol - The consumption of alcohol is directly related to a higher risk of stroke and heart failure. According to a survey of adults ages 18 and older, 84% reported drinking alcohol at some point in their lives across the globe.
High Rate of Tobacco Smoking- For instance, the number of adults smoking cigarettes in the United States is estimated at 30.8 million. There are more than 16 million Americans who suffer from smoking-related diseases.
Prevalence of Unhealthy Lifestyles Among People - It was observed that, there are approximately 677,000 deaths each year in the United States as a result of unhealthy lifestyles, such as cardiovascular disease, cancer, and diabetes, which are linked to nutrition and obesity.

Challenges

Higher Price Associated with Diagnostic Products – Even if heart attack cases are increasing at an alarming rate, heart attack diagnostic procedure cost a fortune owing to high price of diagnostic products. As a result, the population with middle income is expected to slower the adoption rate of heart diagnostic in the forecast period.
Shortage of Skilled Medical Professionals
Inadequate Medicare Reimbursement Policies

Heart Attack Diagnostics Market: Key Insights

Base Year	2024
Forecast Year	2025-2037
CAGR	8.1%
Base Year Market Size (2024)	USD 14.06 billion
Forecast Year Market Size (2037)	USD 38.6 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of heart attack diagnostics is estimated at USD 14.97 billion.

The heart attack diagnostics market size was over USD 14.06 billion in 2024 and is set to cross USD 38.6 billion by the end of 2037, witnessing more than 8.1% CAGR during the forecast period i.e., between 2025-2037. Rise in geriatric population worldwide and prevalence of unhealthy lifestyles among people will drive the market growth.

North America industry is predicted to dominate majority revenue share by 2037, owing to rising incidence of cardiac diseases along with huge spending on healthcare infrastructure by the regional government and other organization that are helpful to facilitate diagnostic equipment at healthcare facilities.

The major players in the market include Abbott Laboratories, ACS Diagnostics, Company, Asahi Kasei Corporation, AstraZeneca PLC, Beckman Coulter, Inc., Hill-Rom Services, Inc, Koninklijke Philips N.V., General Electric Company, Toshiba Corporation, Schiller Americas, inc.

Heart Attack Diagnostics Market Trends